Tumor necrosis factor alpha antagonist drugs and leishmaniasis in Europe

Zanger, P.; Koetter, I.; Kremsner, P. G.; Gabrysch, S.

dc.contributor.author	Zanger, Philipp
dc.contributor.author	Kötter, Ina
dc.contributor.author	Kremsner, Peter
dc.date.accessioned	2014-03-27T16:17:53Z
dc.date.available	2014-03-27T16:17:53Z
dc.date.issued	2012
dc.identifier.issn	1198-743X
dc.identifier.uri	http://hdl.handle.net/10900/50663
dc.language.iso	en	en
dc.publisher	Wiley - Blackwell	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/j.1469-0691.2011.03674.x	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.subject.ddc	570	de_DE
dc.title	Tumor necrosis factor alpha antagonist drugs and leishmaniasis in Europe	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140226071329_01920	de_DE
utue.publikation.seiten	670-676	de_DE
utue.personen.roh	Zanger, P.
utue.personen.roh	Koetter, I.
utue.personen.roh	Kremsner, P. G.
utue.personen.roh	Gabrysch, S.
dcterms.isPartOf.ZSTitelID	Clinical Microbiology and Infection	de_DE
dcterms.isPartOf.ZS-Issue	7	de_DE
dcterms.isPartOf.ZS-Volume	18	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE